PD-1/PD-L1 Checkpoint Inhibitors Are Active in the Chicken Embryo Model and Show Antitumor Efficacy <i>In Ovo</i>
(1) Purpose: To assess the use of the chicken embryo (<i>in ovo</i>) model as an alternative <i>in vivo</i> model for immuno-oncology (IO) drug development, focusing on programmed cell death protein-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) immune checkpoint inhibitors....
Main Authors: | Yan Wang, Xavier Rousset, Chloé Prunier, Paul Garcia, Emilien Dosda, Estelle Leplus, Jean Viallet |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/13/3095 |
Similar Items
-
Association between <i>PD-1</i> and <i>PD-L1</i> Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies
by: Mohammad Hashemi, et al.
Published: (2019-08-01) -
Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
by: Zhengyi Wang, et al.
Published: (2020-11-01) -
<i>PD-1</i> and <i>PD-L1</i> Expression Levels as a Potential Biomarker of Chronic Rhinosinusitis and Head and Neck Cancers
by: Katarzyna Malinowska, et al.
Published: (2023-03-01) -
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer
by: Ander Puyalto, et al.
Published: (2023-09-01) -
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
by: Janice M. Mehnert, et al.
Published: (2019-03-01)